Cargando…

Morphological changes in spectral domain optical coherence tomography guided bevacizumab injections in wet age-related macular degeneration, 12-months results

PURPOSE: To describe retinal changes during Spectral Domain Optical Coherence Tomography (SD-OCT) guided bevacizumab treatment for neovascular age- related macular degeneration (AMD). SETTINGS AND DESIGN: Single center observational study. MATERIALS AND METHODS: We confirmed wet AMD in 47 eyes of 45...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalewski, Janusz, Nawrocki, Jerzy, Izdebski, Bartosz, Michalewska, Zofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065504/ https://www.ncbi.nlm.nih.gov/pubmed/24881600 http://dx.doi.org/10.4103/0301-4738.133485

Ejemplares similares

Spectral domain optical coherence tomography morphology in optic disc pit associated maculopathy
por: Michalewski, Janusz, et al.
Publicado: (2014)

Spectral optical coherence tomography in a patient with type I sialidosis
por: Michalewska, Zofia, et al.
Publicado: (2011)

Long-Term Decrease of Retinal Pigment Epithelium Defects in Large Stage IV Macular Holes with Borders Mechanically Joined during Surgery
por: Michalewska, Zofia, et al.
Publicado: (2011)

Correlation of Choroidal Thickness and Volume Measurements with Axial Length and Age Using Swept Source Optical Coherence Tomography and Optical Low-Coherence Reflectometry
por: Michalewski, Janusz, et al.
Publicado: (2014)

Macular Hole Surgery in a Patient Who Cannot Maintain Facedown Positioning
por: Michalewska, Zofia, et al.
Publicado: (2013)

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration
por: Lee, Junyeop, et al.
Publicado: (2022)

Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation
por: Motarjemizadeh, Qader, et al.
Publicado: (2018)

Changes in Retinal Nerve Fiber Layer Thickness after Two Intravitreal Bevacizumab Injections for Wet Type Age-related Macular Degeneration
por: Entezari, Morteza, et al.
Publicado: (2014)

Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
por: Mukherjee, Chandoshi, et al.
Publicado: (2015)

Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration
por: Topal, Tuncay, et al.
Publicado: (2017)

Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration
por: Kähkönen, Mikael, et al.
Publicado: (2021)

Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography
por: Wei, Wei, et al.
Publicado: (2023)

Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
por: Rishi, Ekta, et al.
Publicado: (2016)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis, Nikolaos, et al.
Publicado: (2016)

Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
por: Pierro, Luisa, et al.
Publicado: (2012)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)

Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age-related macular degeneration: A meta-analysis of randomized controlled trials
por: Wei, Qingquan, et al.
Publicado: (2018)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
Publicado: (2016)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Optical coherence tomography angiography features of macular neovascularization in wet age-related macular degeneration: A cross-sectional study
por: Ahmed, Mahjoub, et al.
Publicado: (2021)

Three-Month Results of Brolucizumab Intravitreal Therapy in Patients with Wet Age-Related Macular Degeneration
por: Michalska-Małecka, Katarzyna, et al.
Publicado: (2021)

Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan
por: Mukai, Ryo, et al.
Publicado: (2023)

Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study
por: Elnahry, Ayman G., et al.
Publicado: (2020)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
por: Torabi, Hamidreza, et al.
Publicado: (2018)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
por: Garba, Adinoyi O., et al.
Publicado: (2010)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin, Laurie, et al.
Publicado: (2015)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Correlation of optical coherence tomography angiography and microperimetry (MP3) features in wet age-related macular degeneration
por: Nagpal, Manish, et al.
Publicado: (2018)

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
por: El Matri, Leila, et al.
Publicado: (2012)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)

Hypertension affects the treatment of wet age‐related macular degeneration
por: Wang, Ting, et al.
Publicado: (2021)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Shaikh, Saad, et al.
Publicado: (2007)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular Degeneration
por: Park, Joo Youn, et al.
Publicado: (2011)

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Singh, Sunil Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_si1a011p8mcu9kqe2pvpgn0219